White House Plan to Limit Generic Drug Exclusivity Could Backfire
February 14, 2018
Bronwyn Mixter
Bloomberg BNA Health Care Blog
Axinn partner Chad Landmon was quoted in the Bloomberg BNA Health Care Blog article, "White House Plan to Limit Generic Drug Exclusivity Could Backfire."
Click here to access the article.